APA (7th ed.) Citation

JR, T., SW, M., RW, S., S, L., DV, N., B, B., . . . J, L. (2001). Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element. Bioorganic & medicinal chemistry letters, 11(16), 2143. https://doi.org/10.1016/s0960-894x(01)00381-x

Chicago Style (17th ed.) Citation

JR, Tagat, McCombie SW, Steensma RW, Lin S, Nazareno DV, Baroudy B, Vantuno N, Xu S, and Liu J. "Piperazine-based CCR5 Antagonists as HIV-1 Inhibitors. I: 2(S)-methyl Piperazine as a Key Pharmacophore Element." Bioorganic & Medicinal Chemistry Letters 11, no. 16 (2001): 2143. https://doi.org/10.1016/s0960-894x(01)00381-x.

MLA (9th ed.) Citation

JR, Tagat, et al. "Piperazine-based CCR5 Antagonists as HIV-1 Inhibitors. I: 2(S)-methyl Piperazine as a Key Pharmacophore Element." Bioorganic & Medicinal Chemistry Letters, vol. 11, no. 16, 2001, p. 2143, https://doi.org/10.1016/s0960-894x(01)00381-x.